Antisense targeting of Mcl-1 has therapeutic potential in gastric cancer.
Zangemeister-Wittke
Uwe
U
Department of Pharmacology, University of Bern, Bern, Switzerland. uwe.zangemeister@pki.unibe.ch
Huwiler
Andrea
A
D000970:Antineoplastic Agents / Q000494:pharmacology*; D045744:Cell Line, Tumor; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D016376:Oligonucleotides, Antisense / Q000494:pharmacology*; D013274:Stomach Neoplasms
D000970:Antineoplastic Agents; D016376:Oligonucleotides, Antisense